143 related articles for article (PubMed ID: 3377765)
1. Activation of heparin cofactor II by heparin oligosaccharides.
Maimone MM; Tollefsen DM
Biochem Biophys Res Commun; 1988 May; 152(3):1056-61. PubMed ID: 3377765
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-inhibitory activity of whale heparin oligosaccharides.
Ototani N; Kodama C; Kikuchi M; Yosizawa Z
J Biochem; 1984 Dec; 96(6):1695-703. PubMed ID: 6530392
[TBL] [Abstract][Full Text] [Related]
3. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.
Bray B; Lane DA; Freyssinet JM; Pejler G; Lindahl U
Biochem J; 1989 Aug; 262(1):225-32. PubMed ID: 2818566
[TBL] [Abstract][Full Text] [Related]
4. Is there a unique sequence in heparin for interaction with heparin cofactor II? Structural and biological studies of heparin-derived oligosaccharides.
Petitou M; Lormeau JC; Perly B; Berthault P; Bossennec V; Sié P; Choay J
J Biol Chem; 1988 Jun; 263(18):8685-90. PubMed ID: 3379040
[TBL] [Abstract][Full Text] [Related]
5. Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II.
Tollefsen DM; Peacock ME; Monafo WJ
J Biol Chem; 1986 Jul; 261(19):8854-8. PubMed ID: 3755134
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulantly active heparin-like molecules from cultured fibroblasts.
Marcum JA; Conway EM; Youssoufian H; Rosenberg RD
Exp Cell Res; 1986 Sep; 166(1):253-8. PubMed ID: 3743657
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic effects of heparin oligosaccharides.
Mattsson C; Palm M; Söderberg K; Holmer E
Ann N Y Acad Sci; 1989; 556():323-32. PubMed ID: 2735663
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the molecular mass dependency of heparin stimulation of heparin cofactor II:thrombin interaction to antithrombin III:thrombin interaction.
Scully MF; Ellis V; Kakkar VV
Thromb Res; 1987 May; 46(3):491-502. PubMed ID: 3603437
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.
Lane DA; Denton J; Flynn AM; Thunberg L; Lindahl U
Biochem J; 1984 Mar; 218(3):725-32. PubMed ID: 6721831
[TBL] [Abstract][Full Text] [Related]
10. Effect of low molecular weight heparin preparations on the inhibition of thrombin by heparin cofactor II.
Tollefsen DM; Sugimori T; Maimone MM
Semin Thromb Hemost; 1990 Oct; 16 Suppl():66-70. PubMed ID: 1962908
[TBL] [Abstract][Full Text] [Related]
11. Pentosan polysulphate: activation of heparin cofactor II or antithrombin III according to molecular weight fractionation.
Scully MF; Ellis V; Kakkar VV
Thromb Res; 1986 Feb; 41(4):489-99. PubMed ID: 2421433
[TBL] [Abstract][Full Text] [Related]
12. Search for the heparin antithrombin III-binding site precursor.
Linhardt RJ; Wang HM; Loganathan D; Bae JH
J Biol Chem; 1992 Feb; 267(4):2380-7. PubMed ID: 1733939
[TBL] [Abstract][Full Text] [Related]
13. Heparin cofactor II is degraded by heparan sulfate and dextran sulfate.
Saito A
Biochem Biophys Res Commun; 2015 Feb; 457(4):585-8. PubMed ID: 25600805
[TBL] [Abstract][Full Text] [Related]
14. Dermatan sulfate and heparin can be fractionated by affinity for heparin cofactor II.
Griffith MJ; Marbet GA
Biochem Biophys Res Commun; 1983 Apr; 112(2):663-70. PubMed ID: 6687802
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant activity of heparin octasaccharide.
Ototani N; Yosizawa Z
J Biochem; 1981 Nov; 90(5):1553-6. PubMed ID: 7338523
[TBL] [Abstract][Full Text] [Related]
16. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
Halldórsdóttir AM; Zhang L; Tollefsen DM
Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
[TBL] [Abstract][Full Text] [Related]
17. Structural features of heparin and their effect on heparin cofactor II mediated inhibition of thrombin.
Kim YS; Linhardt RJ
Thromb Res; 1989 Jan; 53(1):55-71. PubMed ID: 2922702
[TBL] [Abstract][Full Text] [Related]
18. Preparation and structure of heparin lyase-derived heparan sulfate oligosaccharides.
Hileman RE; Smith AE; Toida T; Linhardt RJ
Glycobiology; 1997 Mar; 7(2):231-9. PubMed ID: 9134430
[TBL] [Abstract][Full Text] [Related]
19. The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanism.
O'Keeffe D; Olson ST; Gasiunas N; Gallagher J; Baglin TP; Huntington JA
J Biol Chem; 2004 Nov; 279(48):50267-73. PubMed ID: 15371417
[TBL] [Abstract][Full Text] [Related]
20. Consumption of heparin cofactor II (dermatan sulfate cofactor) and antithrombin during coagulation.
Andersson TR
Thromb Res; 1987 Apr; 46(2):355-62. PubMed ID: 3603428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
